Each day, most people have a set pattern or routine of certain behaviors, including activity. For example, some people may be more active in the morning while others move more in the evening. This is known as a person’s daily activity pattern.

Past studies have linked a consistently highly active daily activity pattern with a healthier cardiometabolic profile, which may help lower a person’s cardiovascular disease risk.

Researchers have also linked a regular daily activity pattern to better cognition, mental health, and improved health in older adults.

For this study, researchers studied the data produced by a wristwatch-like device called an actigraph that was worn by 82 cognitively healthy older adults who were part of the long-running Baltimore Longitudinal Study of Aging.

“For decades now, sleep researchers have used wrist-worn actigraphs to study sleep in older adults,” Dr. Adam Spira, professor in the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health and lead author of this study, explained to Medical News Today.

“The technology — typically an accelerometer — is similar to that used in commercially available fitness trackers that many people use,” he noted.

“Because of growing evidence that sleep disturbances may contribute to the risk of Alzheimer’s disease, my colleagues and I applied for a grant from the National Institute on Aging (NIA) to study links between poor sleep and Alzheimer’s disease, including through the use of wrist actigraphs,” Dr. Spira added. “We received that grant and this work is a direct result.”

Of the 82 study participants with an average age of 76, some had detectable amounts of the protein beta-amyloid in the brain. Amyloid plaques are considered one of the hallmarks of Alzheimer’s disease.

While in this study researchers used a scientific-based wristwatch-type device, would people one day be able to detect early warning signs of Alzheimer’s disease through mainstream fitness and activity trackers like Fitbit, Garmin, and the Apple Watch?

At this point, Dr. Spira said people should not try to interpret data from their own devices as a sign of whether or not they have amyloid in their brains.

“Whether these methods could be used in the future for early detection of Alzheimer’s disease depends on whether further studies support our findings or identify other ‘digital signatures’ of Alzheimer’s disease that can be detected using wearable devices,” he explained.

“If they do, it is conceivable that one day, wearable devices will be used to help identify people at elevated risk for neurological disorders like Alzheimer’s disease. We’re not there yet, though,” Dr. Spira cautioned.

After reviewing this study, Dr. Clifford Segil, a neurologist at Providence Saint John’s Health Center in Santa Monica, CA, not involved in the research, admitted to MNT that he was confused by the study, as Alzheimer’s dementia is a memory loss disorder and not a movement disorder.

“The data supports that the older adults in this study who were amyloid-positive moved better during the early afternoon and had less movement variability in the late afternoon and evening,” Dr. Segil explained.

“I think the authors are trying to provide a framework to look at ‘sundowning,’ which is a phenomenon when patients with Alzheimer’s Dementia become more agitated at night. I am assuming an agitated old adult would have higher movement variability than a non-agitated older adult.”

– Dr. Clifford Segil

“I don’t think a wearable recording ‘wrist actigraphy’ will be used clinically in the diagnosis of a memory loss disorder like Alzheimer’s dementia in the future,” he continued.

“Decreased activity as people age is normal and more worrisome for other medical comorbidities like heart disease, neuropathies, or other medical problems more than dementia. I would love to see this methodology applied to the diagnosis of a neurological movement disorder, Parkinson’s disease,” said Dr. Segil.

MNT also spoke with Dr. Jennifer Bramen, a senior research scientist at the Pacific Neuroscience Institute in Santa Monica, CA, who commented it is too early to conclude if the study’s finding is specific to Alzheimer’s disease or indicative of another overarching condition, such as a sleep disorder, which is common in Alzheimer’s patients.

“It might be valuable to conduct similar research on individuals with and without sleep disorders to assess the potential of this technology in detecting conditions like sleep apnea,” Dr. Bramen continued. “This is because it is a common occurrence and is a well-established modifiable risk factor for heart disease, stroke, and Alzheimer’s disease.”

“I would be skeptical of utilizing wrist-worn devices for detecting Alzheimer’s disease,” she said when asked if people may be able to use mainstream fitness trackers to detect early warning signs of Alzheimer’s disease in the future.

“These devices can make mistakes, potentially causing unnecessary distress and burdening the medical system with unwarranted testing for well patients, while possibly delaying diagnoses for truly impaired individuals,” the expert cautioned.